Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
The evaluation of family impact of recessive dystrophic epidermolysis bullosa using the Italian version of the Family Dermatology Life Quality Index.
[dystrophic epidermolysis bullosa]
Severe
skin
diseases
,
such
as
epidermolysis
bullosa
(
EB
)
,
may
have
a
strong
impact
not
only
on
patients
but
also
on
caregivers
.
A
specific
questionnaire
evaluating
the
family
impact
of
dermatological
conditions
has
been
created
,
the
Family
Dermatology
Life
Quality
Index
(
FDLQI
)
,
but
it
has
not
yet
been
translated
in
Italian
and
validated
.
To
evaluate
the
burden
of
recessive
dystrophic
EB
on
family
caregivers
,
using
for
the
first
time
the
Italian
version
of
the
FDLQI
,
and
to
validate
the
instrument
.
Patients
with
recessive
dystrophic
EB
participated
in
a
postal
survey
enquiring
about
the
burden
of
EB
on
family
caregivers
.
They
completed
the
Family
Strain
Questionnaire
and
the
FDLQI
and
they
marked
on
a
silhouette
of
the
human
body
the
skin
lesion
distribution
.
Data
on
62
family
caregivers
were
collected
.
The
overall
mean
FDLQI
score
was
9
.
8
.
The
most
frequently
reported
problems
were
the
time
spent
on
looking
after
the
patient
,
emotional
distress
,
physical
well-being
,
and
increased
household
expenditure
.
FDLQI
scores
were
higher
in
family
caregivers
of
patients
between
10
and
20
years
.
The
Italian
FDLQI
showed
high
internal
consistency
,
construct
and
convergent
validity
.
Factor
analysis
revealed
the
presence
of
one
factor
structure
underlying
the
items
of
the
FDLQI
,
which
explained
51
.
5
%
of
the
total
variance
,
very
similar
to
the
original
questionnaire
(
55
.
8
%
)
.
The
Italian
version
of
the
FDLQI
seems
to
be
a
useful
tool
to
evaluate
the
impact
of
EB
on
family
caregivers
.
Further
studies
are
necessary
to
test
this
instrument
in
other
dermatological
conditions
.
Diseases
Validation
Diseases presenting
"first time"
symptom
achondroplasia
acute rheumatic fever
adrenal incidentaloma
adrenomyeloneuropathy
alpha-thalassemia
aniridia
aromatase deficiency
canavan disease
carcinoma of the gallbladder
cholangiocarcinoma
classical phenylketonuria
congenital adrenal hyperplasia
congenital toxoplasmosis
cowden syndrome
cushing syndrome
cutaneous mastocytosis
dedifferentiated liposarcoma
dentin dysplasia
dentinogenesis imperfecta
dracunculiasis
dystrophic epidermolysis bullosa
epidermolysis bullosa simplex
erdheim-chester disease
erythropoietic protoporphyria
esophageal adenocarcinoma
esophageal carcinoma
esophageal squamous cell carcinoma
fabry disease
familial mediterranean fever
gm1 gangliosidosis
harlequin ichthyosis
heparin-induced thrombocytopenia
hirschsprung disease
hodgkin lymphoma, classical
holt-oram syndrome
hydrocephalus with stenosis of the aqueduct of sylvius
junctional epidermolysis bullosa
kabuki syndrome
kallmann syndrome
liposarcoma
locked-in syndrome
lymphangioleiomyomatosis
malignant atrophic papulosis
megacystis-microcolon-intestinal hypoperistalsis syndrome
monosomy 21
neuralgic amyotrophy
oculocutaneous albinism
oligodontia
omenn syndrome
oral submucous fibrosis
papillon-lefèvre syndrome
pendred syndrome
phenylketonuria
primary effusion lymphoma
primary hyperoxaluria type 1
severe combined immunodeficiency
sneddon syndrome
triple a syndrome
trochlear dysplasia
von hippel-lindau disease
waldenström macroglobulinemia
well-differentiated liposarcoma
werner syndrome
wiskott-aldrich syndrome
wolf-hirschhorn syndrome
x-linked adrenoleukodystrophy
zellweger syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom